RNA-guided gene activation by CRISPR-Cas9-based transcription factors
about
The rise of regulatory RNACas9 as a versatile tool for engineering biologyTunable and multifunctional eukaryotic transcription factors based on CRISPR/CasCRISPR-Cas9 Genome Editing in DrosophilaRecent Advances in Genome Editing Using CRISPR/Cas9Genome Engineering with TALE and CRISPR Systems in NeuroscienceEmerging Technologies to Create Inducible and Genetically Defined Porcine Cancer ModelsCRISPR/Cas9 and cancer targets: future possibilities and present challengesAdvanced In vivo Use of CRISPR/Cas9 and Anti-sense DNA Inhibition for Gene Manipulation in the BrainBeyond editing: repurposing CRISPR-Cas9 for precision genome regulation and interrogationHow specific is CRISPR/Cas9 really?Applications of Engineered DNA-Binding Molecules Such as TAL Proteins and the CRISPR/Cas System in Biology ResearchThe utility of transposon mutagenesis for cancer studies in the era of genome editing.Enabling functional genomics with genome engineeringStrategies for precision modulation of gene expression by epigenome editing: an overviewCurrent and future prospects for CRISPR-based tools in bacteriaThe New State of the Art: Cas9 for Gene Activation and RepressionThe CRISPR revolution and its impact on cancer researchClassification and evolution of type II CRISPR-Cas systemsEpigenome engineering in cancer: fairytale or a realistic path to the clinic?Synthetic biology in mammalian cells: next generation research tools and therapeuticsElectroporation Knows No Boundaries: The Use of Electrostimulation for siRNA Delivery in Cells and TissuesA CRISPR method for genome engineeringRNA-guided CRISPR-Cas technologies for genome-scale investigation of disease processesCrystal Structure of Cas9 in Complex with Guide RNA and Target DNAEditing the Neuronal Genome: a CRISPR View of Chromatin Regulation in Neuronal Development, Function, and PlasticityCRISPR-Cas9: Tool for Qualitative and Quantitative Plant Genome EditingChromatin regulation at the frontier of synthetic biologyThe CRISPR system can correct or modify the expression of genes responsible for hereditary diseasesDevelopment and applications of CRISPR-Cas9 for genome engineering.A Biophysical Model of CRISPR/Cas9 Activity for Rational Design of Genome Editing and Gene RegulationResources for functional genomics studies in Drosophila melanogasterLigand-binding domains of nuclear receptors facilitate tight control of split CRISPR activityHarnessing CRISPR-Cas9 immunity for genetic engineeringCRISPR-Cas systems for editing, regulating and targeting genomesImproving CRISPR-Cas nuclease specificity using truncated guide RNAsGenome-scale CRISPR-Cas9 knockout screening in human cellsLive cell imaging of low- and non-repetitive chromosome loci using CRISPR-Cas9Cas9-chromatin binding information enables more accurate CRISPR off-target prediction.Stabilization of Foxp3 expression by CRISPR-dCas9-based epigenome editing in mouse primary T cells.
P2860
Q22121998-4F0C18E4-66AB-49CE-B632-E452A70D8547Q24564294-B973B768-8CB2-4257-BD0E-0F3AE76A9FB2Q24606465-6012F530-1915-45A8-8394-0D252076F227Q26314632-652FCA67-E5E0-4882-8502-C280233EC36FQ26744073-3F4830FE-D409-46CB-A204-AA07447774CAQ26752488-D2DC5C77-AAC1-4C7D-BDB2-81D6F86A74EBQ26765901-466466AD-716B-4C73-B9AB-1560CD56A059Q26769907-8B23F23A-C56C-4548-B5B1-42C7FE56A596Q26770355-D9A4936C-ED32-4276-BF77-86287F3B2E51Q26775746-97905E5B-8697-420A-B403-45CF61EEA5B1Q26777801-85D181CE-291F-4D6B-8C71-6B716A0F4834Q26781399-19D6B212-AD77-4297-A4F0-37EDD54D06DAQ26781762-62EBBFCC-7694-4264-B4D7-1CE96B64F5ABQ26782747-57F5E650-7E1F-4C34-B139-EE3BB8B4B11BQ26782876-8050ED95-2403-4B23-A867-ADE4A71E2E89Q26783837-4CE04551-AED6-4284-B55F-67B94414808AQ26787037-3C6AD2C7-C007-42DA-AB11-275C8DC6BBB7Q26824997-C0E76213-A721-419F-926B-337A317FC164Q26850610-92BF0095-7B90-4F5E-81D4-755C5BFA1C87Q26861350-ECF09FEC-93FF-42BB-9E1A-120C538DF28CQ26995293-845782CC-8E28-45D8-91E0-04D2F824BC73Q26998879-D766E0E4-C185-4AEA-B567-BC22AF2336BFQ27000786-7F67DA78-A177-4AC0-A8D7-0CE573CCE364Q27025675-680185A5-16E3-42FC-B988-F2CDEAD3215EQ27681727-C1FFD4FD-6B5B-4570-87DB-BEB93651BE6EQ28075883-7B92323C-D022-4D10-A79C-0969D37C9473Q28079519-E0F42A7B-4B63-4FED-A3A1-44F191C58D37Q28083608-6CE3DC0F-1C5A-442B-930B-6CCD33FE87BCQ28085767-740C322E-D6E9-4CB7-BD90-DA50C8A6A6D6Q28241526-B614E3ED-B5D2-4FDE-96D9-2966B4C59EB8Q28552981-9762B54A-902F-4422-A798-5B9A7D663AB1Q28657863-5ACD6B1D-0FE2-40F2-9B30-F401BDEF7AE5Q28831343-15BB60B0-6254-4BFD-9543-DEB202C00D90Q29114115-020759B1-85B2-41DA-8C26-60856BF67545Q29615781-0918381A-3061-42AC-977B-6CE6A7AA6AD9Q29616043-1D816993-44E7-4D67-BEB6-57B7ABC1C2ACQ29616044-AEB02BED-157F-476E-AEB8-52542FFE0E59Q30252964-723A647C-49E5-49D0-AB1E-06B823BB95CFQ30279249-97A21118-437B-4550-9E9B-DA96D7727FB6Q30356570-DE8945DF-3D60-4899-A29C-EFCCC0BB1DAE
P2860
RNA-guided gene activation by CRISPR-Cas9-based transcription factors
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
RNA-guided gene activation by CRISPR-Cas9-based transcription factors
@ast
RNA-guided gene activation by CRISPR-Cas9-based transcription factors
@en
RNA-guided gene activation by CRISPR-Cas9-based transcription factors
@nl
type
label
RNA-guided gene activation by CRISPR-Cas9-based transcription factors
@ast
RNA-guided gene activation by CRISPR-Cas9-based transcription factors
@en
RNA-guided gene activation by CRISPR-Cas9-based transcription factors
@nl
prefLabel
RNA-guided gene activation by CRISPR-Cas9-based transcription factors
@ast
RNA-guided gene activation by CRISPR-Cas9-based transcription factors
@en
RNA-guided gene activation by CRISPR-Cas9-based transcription factors
@nl
P2093
P2860
P50
P3181
P356
P1433
P1476
RNA-guided gene activation by CRISPR-Cas9-based transcription factors
@en
P2093
Ami M Kabadi
Andrew F Adler
Charles A Gersbach
Christopher M Vockley
D Dewran Kocak
David G Ousterout
Gregory E Crawford
Katherine A Glass
Lauren R Polstein
Pratiksha I Thakore
P2860
P2888
P304
P3181
P356
10.1038/NMETH.2600
P407
P577
2013-07-25T00:00:00Z
P5875
P6179
1024354143